GET INVOLVED

Business Initiatives

Join Us

Donate

Contact Us

WANT YOUR HEPATITIS B QUESTION ANSWERED?

Call and leave a message on our support line at 415-336-2629 (Cantonese, Mandarin and English)

  • Facebook - White Circle

Dynavax Announces FDA Approval

November 10, 2017

 

 

A new milestone in Hep B prevention has been achieved. Yesterday, on November 9th, the FDA approved HEPLISAV-B, the first new hepatitis B vaccine in the United States in more than 25 years and the only two-dose hepatitis B vaccine for adults. Dynavax expects to commercially launch HEPLISAV-B in the United States in the first quarter of 2018.

 

This 2 shot vaccine could greatly increase successful vaccination rates given almost half of adults fail to complete the hepatitis B vaccination series within one year. Decreasing the number of shots could greatly increase completion of the series.

 

More info here: http://investors.dynavax.com/releasedetail.cfm?ReleaseID=1048181

 

Share on Facebook
Share on Twitter
Please reload

Featured Posts

12th Annual Be a Hero Awards Gala & Fundraiser, October 18, 2019

July 31, 2019

1/6
Please reload

Recent Posts